January 29, 2026
LA JOLLA—The Salk Institute welcomes two new Miembros no residentes, UC Berkeley professor Andrew Dillin, PhD, and UC San Diego professor Christopher Glass, MD, PhD. The two scientists join a group of eminent scientific advisors who guide Salk’s leadership.

“Andy and Chris are world-renowned researchers and great partners to Salk,” says Salk President Dr. Gerald Joyce, médico y doctor en Medicina. “Their careers highlight the importance of studying the genomic and molecular mechanisms of health, aging, and disease, and their insights will help strengthen and guide Salk’s scientific strategy in these fields.”
Andrew Dillin is a professor of genetics, genomics, and development at UC Berkeley and a Howard Hughes Medical Investigator. Dillin was a faculty member at Salk from 2002 to 2012 and served as director of the Institute’s Glenn Center for Aging Research. His lab’s research on mitochondrial function and dysfunction in the aging process informs our understanding and treatment of aging-related conditions such as Alzheimer’s, Huntington’s, and Parkinson’s diseases.
Dillin earned his bachelor’s degree in biochemistry at the University of Nevada, Reno, completed his PhD in molecular and cell biology from UC Berkeley, and did his postdoctoral training at UC San Francisco. He currently serves as editor-in-chief of the scientific journal Genes and Development, and his numerous awards include the Lurie Prize, the Nathan Shock Award, and the McKnight Neuroscience of Brain Disorders Award.

Christopher Glass is a professor of cellular and molecular medicine at UC San Diego and director of the university’s Center for Epigenetics. His lab studies the genetic and molecular mechanisms that control macrophage and microglia function in health and disease.
Glass earned his bachelor’s degree in biophysics at UC Berkeley and his MD and PhD at UC San Diego before completing his residency at Brigham and Women’s Hospital at Harvard Medical School. He later became one of the founding members of the Department of Cellular and Molecular Medicine at UC San Diego. Glass is an elected member of the American Academy of Arts and Sciences, the National Academy of Medicine, and the National Academy of Sciences.
Salk Nonresident Fellows serve as members of the faculty for renewable six-year terms. These individuals come from world-renowned academic organizations where they have achieved high levels of success in research areas that are represented at the Salk Institute. They visit Salk each year to help benchmark the Institute by advising on the scientific progress of its faculty and on the effectiveness of its existing and proposed scientific programs. The Nonresident Fellows also play a key decision-making role in the appointment and promotion of Salk faculty members.
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.